Harvest of CTCs From MBC Patients Using the Parsortix™ PC1 System

CompletedOBSERVATIONAL
Enrollment

421

Participants

Timeline

Start Date

March 29, 2018

Primary Completion Date

May 16, 2019

Study Completion Date

December 31, 2019

Conditions
Healthy VolunteersBreast Cancer, Metastatic
Interventions
DIAGNOSTIC_TEST

Blood draw

Blood collected will be processed on Parsortix PC1 system for capture and harvest of circulating tumor cells to be used in subsequent evaluations.

Trial Locations (4)

14642

University of Rochester Medical Center Wilmot Cancer Institute, Rochester

60611

Northwestern University, Chicago

77030

UT MD Anderson Cancer Center, Houston

90033

University of Southern California, Los Angeles

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Angle plc

INDUSTRY

NCT03427450 - Harvest of CTCs From MBC Patients Using the Parsortix™ PC1 System | Biotech Hunter | Biotech Hunter